SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
S evere a cute r espiratory s yndrome co rona v irus 2 (SARS-CoV-2) has caused a global pandemic of COVID-19, resulting in cases of mild to severe respiratory distress and significant mortality. The global outbreak of this novel coronavirus has now infected >20 million people worldwide, with >5 million cases in the United States (11 August 2020). The development of diagnostic and research tools to determine infection and vaccine efficacy is critically needed.
Article activity feed
-
-
SciScore for 10.1101/2020.06.17.158527: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding Samples were not blinded before performing each experiment. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources SARS-CoV-2 Pseudovirus assay: The SARS-CoV-2 pseudovirus was produced by co-transfection of HEK293T cells with 1:1 ratio of DNA plasmid encoding SARS-CoV-2 S protein (GenScript) and backbone plasmid pNL4-3. HEK293Tsuggested: NoneFor neutralization assay, serially diluted samples were incubated with pseudovirus at room temperature for 90 minutes and added to 10,000 ACE2-293T cells in 200uL … SciScore for 10.1101/2020.06.17.158527: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding Samples were not blinded before performing each experiment. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources SARS-CoV-2 Pseudovirus assay: The SARS-CoV-2 pseudovirus was produced by co-transfection of HEK293T cells with 1:1 ratio of DNA plasmid encoding SARS-CoV-2 S protein (GenScript) and backbone plasmid pNL4-3. HEK293Tsuggested: NoneFor neutralization assay, serially diluted samples were incubated with pseudovirus at room temperature for 90 minutes and added to 10,000 ACE2-293T cells in 200uL TPCK media (DMEM supplemented with 1%BSA, 25mM HEPES, 1ug/ml of TPCK and 1X Penicillin-Streptomycin) in 96-well tissue culture plates, and incubated at 37C and 5% CO2 for 72 hours. ACE2-293Tsuggested: NoneSoftware and Algorithms Sentences Resources The data collected was analyzed using the protein conjugated analysis from ASTRA software (Wyatt technology). ASTRAsuggested: (ASTRA, RRID:SCR_016255)The regeneration solution was made using 3-parts 8M guanidine hydrochloride and 1-part 1M sodium hydroxide. Statistics: Statistical analyses were performed using GraphPad Prism 8 software. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-